US Financial 15 Split Corp. Preferred Dividend Declared
TORONTO, ONTARIO--(Marketwired - May 18, 2017) - US Financial 15 Split Corp ("US Financial 15") declares its monthly distribution of $0.03776 for each Preferred share, or 5.25% annually based on the previous month end net asset value. Distributions are payable June 9, 2017 to shareholders on record as at May 31, 2017.
US Financial 15 invests in a portfolio consisting of 15 U.S. financial services companies as follows: American Express, Bank of America, Bank of New York Mellon Corp., Citigroup, CME Group Inc., Fifth Third Bancorp, The Goldman Sachs Group, J.P. Morgan Chase & Co., Morgan Stanley, PNC Financial Services group Inc., Regions Financial Corp., State Street Corp., SunTrust Banks, U.S. Bancorp, and Wells Fargo.
Day 1 of the London Blockchain Conference kicks off today with world-renowned marketing and business entrepreneur and professor Scott Galloway taking the stage.
Tech influencer Lilly Douse will also host this year's conference. She will bring her...
Sungrow, the global leading PV inverter and energy storage system provider, has forged a strategic partnership with Larsen & Toubro to supply 165MW PV inverters and 160MW/760MWh energy storage systems for AMAALA, a prestigious destination in Saudi...
Allied Market Research published a report, titled, "Managed Learning Service Market by Type (Sourcing External Training, L&D Administration, Supplier Management, and Others), Enterprise Size (Small & Medium Enterprises and Large Enterprises),...
Configit, a global leader in Configuration Lifecycle Management (CLM), today announced that Knauf Digital GmbH, a subsidiary of the Knauf Group, has implemented Configit Ace® SaaS to accelerate its Configure, Price, Quote (CPQ) process. Configit's...
Today sees the launch of the Leandro Herrero Institute; a membership community for leaders and professionals who want to directly benefit from Leandro's unique experience, expertise and insights. This was gained from his 25+ years pioneering a better...
Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide range of hard-to-treat cancers, today announces the completion of a $120m Series B financing to fund the development of its...
